Envoy Medical, Inc. (COCH): Nasdaq/NYSE listing notice — Envoy Medical receives Nasdaq deficiency notice for low market value of listed securities

Envoy Medical, Inc.

Nasdaq notified Envoy Medical on Feb 25, 2025 that market value of listed securities fell below $35M for 31 consecutive business days.
Company has 180 days, until Aug 25, 2025, to regain compliance by having MVLS exceed $35M for 10 consecutive business days.
Failure to regain compliance could result in delisting from Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Envoy Medical, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

February 25, 2025, Envoy Medical, Inc. (the “Company”) received a deficiency notification letter (the “Notification Letter”) from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(2) (the “Rule”) because the market value of the Company’s listed securities did not meet the minimum of $35,000,000 for the period for 31 consecutive business days between January 7, 2025 and February 24, 2025. Pursuant to Nasdaq’s Listing Rules, the Company will return to compliance if the market value of its listed securities exceeds $35,000,000 for t

View on SEC.gov

Browse all listing & compliance notices →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-019425

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.